|
Effectiveness, per 1000 clients
|
Costs per DALY averted, US$
|
---|
HIV/AIDS
|
Cervical cancer
| |
---|
Deaths
|
DALYs
|
Deaths
|
DALYs
|
HTC
|
VMMC
|
HIV C&T
|
CCS
|
---|
Study arm
|
SOC
|
4160
|
96796
|
3765
|
83966
|
—
|
—
|
—
| |
Arm 2
|
4240
|
83970
|
3350
|
78808
|
$ 7890
|
$ 377
|
$ 81
|
$ 607
|
Arm 3
|
3708
|
65078
|
3254
|
77741
|
$ 3180
|
$ 162
|
$ 33
|
$ 106
|
Difference
|
Deaths averted
|
DALYs
|
Deaths averted
|
DALYs
| | | | |
SOC – Arm2
|
−80
|
12826
|
415
|
5157
| | | | |
SOC – Arm 3
|
452
|
31718
|
511
|
6224
| | | | |
- Note: Family planning not included in the incremental cost-effectiveness calculations as the intervention did not increase uptake of services